X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11200) 11200
Book Review (1284) 1284
Publication (798) 798
Book Chapter (56) 56
Conference Proceeding (28) 28
Dissertation (7) 7
Magazine Article (4) 4
Presentation (4) 4
Book / eBook (2) 2
Data Set (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8446) 8446
ophthalmology (7560) 7560
humans (7302) 7302
intravitreal injections (5571) 5571
male (5007) 5007
female (4718) 4718
aged (3453) 3453
bevacizumab (3241) 3241
middle aged (3234) 3234
ranibizumab (2907) 2907
vascular endothelial growth factor a - antagonists & inhibitors (2619) 2619
macular degeneration (2398) 2398
tomography, optical coherence (2291) 2291
treatment outcome (2277) 2277
angiogenesis inhibitors - therapeutic use (2081) 2081
intravitreal injection (2034) 2034
retrospective studies (1987) 1987
angiogenesis inhibitors - administration & dosage (1940) 1940
aged, 80 and over (1887) 1887
visual acuity (1850) 1850
animals (1811) 1811
fluorescein angiography (1788) 1788
eye diseases (1736) 1736
visual acuity - physiology (1610) 1610
endothelial growth-factor (1606) 1606
follow-up studies (1589) 1589
vascular endothelial growth factor (1574) 1574
adult (1466) 1466
macular edema - drug therapy (1417) 1417
genetic structures (1323) 1323
retina (1266) 1266
injection (1258) 1258
diabetic retinopathy (1205) 1205
prospective studies (1189) 1189
intravitreal bevacizumab (1173) 1173
sense organs (1074) 1074
care and treatment (1054) 1054
macular edema (1034) 1034
optical coherence tomography (1028) 1028
choroidal neovascularization - drug therapy (974) 974
choroidal neovascularization (947) 947
injections (901) 901
antibodies, monoclonal, humanized - therapeutic use (881) 881
vitrectomy (873) 873
therapy (870) 870
photodynamic therapy (859) 859
wet macular degeneration - drug therapy (852) 852
age-related macular degeneration (850) 850
diabetic retinopathy - drug therapy (847) 847
antibodies, monoclonal, humanized - administration & dosage (832) 832
diabetic macular edema (821) 821
edema (807) 807
medicine & public health (806) 806
antibodies, monoclonal, humanized (796) 796
neovascularization (776) 776
macular degeneration - drug therapy (771) 771
pharmacology & pharmacy (758) 758
triamcinolone (757) 757
analysis (742) 742
surgery (738) 738
retinopathy (735) 735
glucocorticoids - administration & dosage (724) 724
macular edema - etiology (712) 712
eye (685) 685
vitreous body (685) 685
diabetes (679) 679
triamcinolone acetonide (678) 678
time factors (666) 666
endophthalmitis (664) 664
retina - pathology (657) 657
avastin (615) 615
rabbits (607) 607
degeneration (603) 603
research (590) 590
abridged index medicus (588) 588
risk factors (583) 583
disease models, animal (578) 578
physiological aspects (562) 562
angiogenesis inhibitors - adverse effects (558) 558
drug therapy (558) 558
retinal vein occlusion (538) 538
intravitreal triamcinolone (527) 527
efficacy (522) 522
intraocular pressure (521) 521
patients (520) 520
visual acuity - drug effects (518) 518
safety (516) 516
vegf (511) 511
retinal vein occlusion - drug therapy (503) 503
fundus oculi (500) 500
intravitreal (500) 500
macular edema - physiopathology (500) 500
verteporfin (498) 498
macular edema - diagnosis (483) 483
antibodies, monoclonal - administration & dosage (478) 478
glaucoma (473) 473
ranibizumab - administration & dosage (468) 468
ranibizumab - therapeutic use (466) 466
aflibercept (464) 464
age (458) 458
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10239) 10239
German (321) 321
Korean (222) 222
French (221) 221
Spanish (70) 70
Russian (33) 33
Japanese (28) 28
Chinese (24) 24
Polish (21) 21
Portuguese (19) 19
Czech (15) 15
Romanian (14) 14
Turkish (9) 9
Hungarian (7) 7
Slovenian (2) 2
Swedish (2) 2
Danish (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, ISBN 9789814571463
Intravitreal injections (injections into the eye) are a new form of treatment for various conditions such as age-related macular degeneration, diabetic eye... 
Eye | Vision disorders | Intravitreal Injections | therapy | methods | nursing | Ophthalmology | Eye Diseases | Diseases
Web Resource
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 6, pp. 1257 - 1262
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 1/2008, Volume 246, Issue 1, pp. 81 - 87
Vascular endothelial growth factor (VEGF) plays an important role in many diseases of the posterior pole that are characterized by macular edema and/or... 
Angiogenesis | Intravitreal bevacizumab | Medicine & Public Health | Choroidal neovascularization | Age-related macular degeneration | Proliferative diabetic retinopathy | Diabetic macular edema | Ophthalmology | Safety | intravitreal bevacizumab | PHOTODYNAMIC THERAPY | choroidal neovascularization | angiogenesis | COHERENCE TOMOGRAPHY FINDINGS | BARRIER | MACULAR DEGENERATION | VERTEPORFIN | PHARMACOKINETICS | safety | PEGAPTANIB | GROWTH-FACTOR APTAMER | OPHTHALMOLOGY | age-related macular degeneration | proliferative diabetic retinopathy | diabetic macular edema | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | BREAKDOWN | Diabetic Retinopathy - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - drug therapy | Bevacizumab | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Time Factors | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Vitreous Body | Adult | Female | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Retinal Vein Occlusion - physiopathology | Macular Degeneration - physiopathology | Treatment Outcome | Visual Acuity | Choroidal Neovascularization - physiopathology | Retreatment | Injections | Retinal Vein Occlusion - drug therapy | Macular Edema - physiopathology | Macular Edema - drug therapy | Aged | Endothelial growth factors | Safety and security measures | Angiogenesis inhibitors | Index Medicus
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 8/2013, Volume 251, Issue 8, pp. 1885 - 1890
Journal Article
Journal Article
Retina, ISSN 0275-004X, 01/2014, Volume 34, Issue 1, pp. 18 - 23
Purpose: To report on the occurrence of endophthalmitis after intravitreal injections (IVI) in two different settings: office-based and operating room.... 
Retinal vein occlusion | Diabetic retinopathy | Intravitreal injection | Age-related macular degeneration | Ranibizumab | Endophthalmitis | Macular edema | Triamcinolone | Bevacizumab | BEVACIZUMAB AVASTIN INJECTION | FLORA | retinal vein occlusion | MACULAR DEGENERATION | RISK | intravitreal injection | BLEB-ASSOCIATED ENDOPHTHALMITIS | diabetic retinopathy | ANTIMICROBIAL RESISTANCE | ranibizumab | bevacizumab | OPHTHALMOLOGY | GROWTH-FACTOR AGENTS | macular edema | endophthalmitis | OUTCOMES | age-related macular degeneration | triamcinolone | TOPICAL ANTIBIOTICS | Antibodies, Monoclonal, Humanized - adverse effects | Glucocorticoids - administration & dosage | Intravitreal Injections | Humans | Triamcinolone Acetonide - adverse effects | Endophthalmitis - epidemiology | Endophthalmitis - etiology | Incidence | Ambulatory Surgical Procedures - statistics & numerical data | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Wet Macular Degeneration - drug therapy | Retinal Vein Occlusion - drug therapy | Operating Rooms - statistics & numerical data | Macular Edema - drug therapy | Retrospective Studies | Angiogenesis Inhibitors - adverse effects | Glucocorticoids - adverse effects | Triamcinolone Acetonide - administration & dosage | Endophthalmitis - drug therapy | Index Medicus
Journal Article